Organization Profile

You just read:

Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102

News provided by

Taiho Pharmaceutical Co., Ltd.

May 31, 2012, 00:01 ET